MAP3K7 C-Terminal Like (MAP3K7CL) Peptide
Quick Overview for MAP3K7 C-Terminal Like (MAP3K7CL) Peptide (ABIN974196)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-C21orf7 antibody (Catalog #: ARP42552_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
Background
-
C21orf7 plays a critical role in the TGF-beta signaling transduction pathway.
Alias Symbols: TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4, HC21ORF7, MAP3K7CL
Protein Interaction Partner: GPS2,TAB3,GPS2,TAB3
Protein Size: 242 -
Molecular Weight
- 27 kDa
-
Gene ID
- 56911
-
NCBI Accession
- NM_020152, NP_064537
-
UniProt
- P57077
Target
-